|
Volumn 145, Issue 1, 2008, Pages 106-113
|
Cost Analysis of Glaucoma Medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIGLAUCOMA AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETAXOLOL;
BIMATOPROST;
BRIMONIDINE;
BRINZOLAMIDE;
CARBONATE DEHYDRATASE INHIBITOR;
CARTEOLOL;
DORZOLAMIDE;
DORZOLAMIDE PLUS TIMOLOL;
LATANOPROST;
LEVOBUNOLOL;
METIPRANOLOL;
PROSTAGLANDIN DERIVATIVE;
TIMOLOL;
TIMOLOL MALEATE;
TRAVOPROST;
ARTICLE;
CALCULATION;
DRUG COST;
DRUG PACKAGING;
EXPERIMENTAL STUDY;
GLAUCOMA;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
ANTIHYPERTENSIVE AGENTS;
COSTS AND COST ANALYSIS;
DRUG COSTS;
DRUGS, GENERIC;
GLAUCOMA;
HUMANS;
MODELS, THEORETICAL;
OPHTHALMIC SOLUTIONS;
PRESCRIPTIONS, DRUG;
PROSPECTIVE STUDIES;
|
EID: 37249005799
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ajo.2007.08.041 Document Type: Article |
Times cited : (72)
|
References (8)
|